Risk attribution — Morton Auer

v1.0 · cal 2026-05-22

Component breakdown showing every feature that contributed to this patient's risk score.

Computed = stored(J vs J)Open patient detail

Computed score

100

Group J · Stage IV / progressing

Stored A–J score

Group J · Stage IV / progressing

Score buildup

Baseline 5 + +174 positive = 100

BaselineDemographicSymptomComorbidityImagingProcedurePathologyTreatmentResponse

Demographic

Subtotal +5

Age ≥ 70
Advanced age is an independent risk factor for PDAC.
Evidence: Current age 105· Threshold: 70 years
+5

Symptom

Subtotal +14

Abdominal pain at age ≥ 50
Unexplained abdominal pain in a patient over 50 warrants pancreas evaluation.
Evidence: Onset 2022-09-02· Triggers PANDA group C
+14

Comorbidity

Subtotal +13

Has chronic condition(s)
Chronic disease burden warrants ongoing surveillance.
Evidence: 3 active conditions
+13

Imaging

Subtotal +10

CT of abdomen on record
Imaging suggests the patient has been worked up for pancreatic concern.
Evidence: CT on 2023-04-10
+10

Procedure

Subtotal +42

EUS performed
EUS is the highest-resolution modality for sub-cm pancreatic lesions; performance implies clinical concern.
Evidence: Endoscopic ultrasonography of pancreas on 2023-01-18· Triggers PANDA group G
+20
Tissue diagnosis procedure
Biopsy or resection indicates definitive workup or treatment.
Evidence: EUS-guided fine needle aspiration of pancreas on 2023-01-21
+22

Pathology

Subtotal +40

Pancreatic tumor confirmed
Confirmed pancreatic malignancy is the defining factor for groups H–J.
Evidence: Pancreatic adenocarcinoma TNM stage IV· Triggers PANDA group H
+25
Stage IV disease
Metastatic disease puts the patient in the highest-risk group with palliative-intent management.
Evidence: Pancreatic adenocarcinoma TNM stage IV
+15

Treatment

Subtotal +20

Active chemotherapy
Active cytotoxic therapy implies confirmed malignancy with treatment intent.
Evidence: Oxaliplatin 85 MG/M2 Injection, Irinotecan 180 MG/M2 Injection· Triggers PANDA group I
+20

Response

Subtotal +30

Disease progression documented
RECIST PD recorded — escalates urgency and changes treatment plan.
Evidence: At least one RECIST PD event in tumor_measurements· Triggers PANDA group J
+18
Patient deceased
Score retained for cohort/historical analytics; treatment intent is post-mortem.
Evidence: Death recorded 1974-09-18
+12

The Risk Engine computed group (J) is derived purely from the feature contributions above. The stored A–J group (J) comes from the cascade classifier in scripts/classify-risk.ts. Divergence between the two indicates a classifier rule that the scoring weights haven't captured, or vice versa — useful for calibration.